[NMusers] Open position at BMS - Quantitative Clinical Pharmacology/Pharmacometrics - MBMA

[Bouillon-Pichault, Marion]

Dear All,

We have an open position in our department:  Quantitative Clinical 
Pharmacology/Pharmacometrics - MBMA

https://www.bms.com/job-seekers/job-search-results/job-details.html?requisitionId=R1122083

https://www.linkedin.com/jobs/view/558705154/


Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to 
discover, develop and deliver innovative medicines that help patients prevail 
over serious diseases.
One shared journey is moving us forward at Bristol-Myers Squibb. Around the 
world, we are passionate about making an impact on the lives of patients with 
serious disease. Empowered to apply our individual talents and ideas so that we 
can learn and grow together.  Driven to make a difference, from innovative 
research to hands-on community support.  Bristol-Myers Squibb recognizes the 
importance of balance and flexibility in our work environment. We offer a wide 
variety of competitive benefits, services and programs that provide our 
employees the resources to pursue their goals, both at work and in their 
personal lives.

The Scientist will join the Quantitative Clinical Pharmacology group to perform 
model-based meta-analysis, facilitate model-based drug development and provide 
broad pharmacometrics strategic leadership.

Position Description and Responsibilities:

The Clinical Pharmacology & Pharmacometrics (CP) department is searching for 
a Principal Scientist with expertise in Pharmacometrics (Pm) and Model-Based 
Meta-Analysis (MBMA). The Principal Scientist will join the Quantitative 
Clinical Pharmacology (QCP) group to conduct Pm analyses that will facilitate 
model-based drug development.  This individual will be responsible for:  (1) 
collaborating with cross-functional team members to help address key program 
and portfolio level questions, (2) developing and implementing Pm/MBMA analysis 
strategies to address key questions, (3) ensuring alignment of the Pm/MBMA 
strategy with the global clinical development plan, (4) reporting and 
interpretation of Pm/MBMA analysis results, (5) contributing to Clinical 
Pharmacology regulatory submissions (pre- and post-approval), (6) serving as a 
Pm and MBMA expert for both internal colleagues and to the external scientific 
clinical pharmacology/pharmacometrics community.  This position will provide an 
opportunities for internal and external growth/leadership in both Pm and 
Clinical Pharmacology.

Position Requirements:


* Ph.D., PharmD, and/or M.D. in 
biological/medical/pharmaceutical sciences, engineering, or a related field, 
with 3+ years of experience (industry and/or academia) in Pm analyses (e.g., 
model-based meta-analysis, population pharmacokinetics, exposure-response and 
disease progression). Candidates with M.S. degree and significantly more 
industry experience will also be considered

* Excellent understanding of theory, principles and statistical 
aspects of advanced mathematical modeling and simulation

* Thorough understanding of the basic principles of 
pharmacokinetics and pharmacodynamics

* Experience in development and application of model-based 
meta-analyses

* Ability to communicate internally and externally on topics 
related to Clinical Pharmacology, Pharmacometrics and Model-Based Meta-Analysis

* Ability to keep up-to-date with and propose the 
implementation of scientific and technological developments in Pharmacometrics

* Extensive hands-on experience with modeling/data analysis 
tools such as S-PLUS/R, NONMEM, Monolix, Matlab, S-ADAPT, WinBUGS/OpenBUGS, 
and/or other commonly used platforms

* Ability to interact as a pharmacometrics expert with matrix 
project teams consisting of experts from diverse functional areas

* Experience supporting clinical development in the Oncology is 
preferred

* Knowledge of current practices and issues in clinical 
pharmacology, bioanalytical, biopharmaceutics, toxicology and regulatory 
affairs would be a plus



Regards,

Marion Bouillon-Pichault, PharmD PhD

Senior Principal Scientist
CP Quantitative Clinical Pharmacology
R/Exploratory Clinical Research
[bms301 resized3]
Office: 609-252-5788
Route 206 & Province Line Road
Princeton, NJ 08543

[NMusers] REGISTRATION OPEN for 3-day NONMEM/PDxPoP Workshop and 1-day TMDD Lecture - February 13-16 - San Francisco, California

[Wilhelm-Lear, Lisa]

SEATS ARE STILL AVAILABLE  REGISTRATION ENDS ON FEBRUARY 9!

Please contact me directly if you are interested.

Introductory/Intermediate NONMEM & PDxPoP Workshop – February 13 & 14
http://www.iconplc.com/news-events/events/workshops/introductoryintermediate--1/index.xml

New and Advanced Features of NONMEM 7 Workshop – February 15
http://www.iconplc.com/news-events/events/workshops/new-and-advanced-features-9/index.xml

Modeling Biologics with Target-Mediated Disposition Lecture – February 16
http://www.iconplc.com/news-events/events/workshops/modeling-biologics-with-t/index.xml



Lisa R. Wilhelm-Lear
Customer Service Lead
NONMEM / PDxPoP Software

Phone:  301-944-6771
Fax: 215-789-9549
lisa.wilh...@iconplc.com
www.iconplc.com

ICON plc made the following annotations.
--
This e-mail transmission may contain confidential or legally privileged 
information that is intended only for the individual or entity named in the 
e-mail address. If you are not the intended recipient, you are hereby notified 
that any disclosure, copying, distribution, or reliance upon the contents of 
this e-mail is strictly prohibited. If you have received this e-mail 
transmission in error, please reply to the sender, so that ICON plc can arrange 
for proper delivery, and then please delete the message.

Thank You,

ICON plc
South County Business Park
Leopardstown
Dublin 18
Ireland
Registered number: 145835